Applied Molecular Transport (AMT) is a privately held, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platforms to create transformative oral biological therapies for patients with severe autoimmune, metabolic and inflammatory diseases. The company is headquartered in South San Francisco, California.
In the News
Applied Molecular Transport Debuts with First Patient Dosed in Phase 1b Clinical Trial of AMT-101 in Adults with Ulcerative Colitis
No events scheduled at this time.